Policy & Regulation: Page 33


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL David J. Kudla Jr. Advancis Creates VP of Quality Assurance Position Advancis Pharmaceutical, a pharmaceutical company focused on developing and commercializing novel anti-infective products, has named David ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive Appointments and Promotions in the Healthcare Industry Featured Talent: Pharma POOL Joy A. Amundson, Baxter International Bruce McGillivray, Baxter International Jim Utts, Baxter International Brian Crombie , Biovail David Keefer, Biovail Charles Rowland, Biovail Paul Duffy, Ala...

    By PharmaVoice Team • Jan. 2, 2008
  • rare disease ribbon Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Rare diseases

    As drug developers find promise in the rare diseases, deals and treatments are on the rise

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What’s New

    New Healthcare-related Products, Services, and Companies Featured Briefs: PRA International Launches Pediatric Clinical Development and Research Center PhRMA Adopts Clinical-Trial Principles LabConnect Completes inREACH Acquisition Life Science Insights Offers Intelligence Service GSP C...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice -- Letters

    Medicare Part D: It’s “Crunch Time” and Many Brand Teams Aren’t Ready “If Medco called tomorrow to ask how I would contract my product under Part D, I couldn’t tell them. The trouble is, they just might call tomorrow!” I’ve heard similar quotes from numerous brand directors over the past month as...

    By PharmaVoice Team • Jan. 2, 2008
  • Trendline

    Increasing diversity in clinical trials

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.